Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Evidence supporting the use of second generation antipsychotics (SGAs) in the treatment of acute depression with mixed features (MFs) associated with bipolar disorder (BD) is scarce and equivocal. Therefore, we conducted a systematic review and preliminary meta-analysis investigating SGAs in the treatment of acute BD depression with MFs. Two authors independently searched major electronic databases from 1990 until September 2015 for randomized (placebo-) controlled trials (RCTs) or open-label clinical trials investigating the efficacy of SGAs in the treatment of acute bipolar depression with MFs. A random-effect meta-analysis calculating the standardized mean difference (SMD) between SGA and placebo for the mean baseline to endpoint change in depression as well as manic symptoms score was computed based on 95% confidence intervals (CI). Six RCTs and one open-label placebo-controlled studies (including post-hoc reports) representing 1023 patients were included. Participants received either ziprasidone, olanzapine, lurasidone, quetiapine or asenapine for an average of 6.5 weeks across the included studies. Meta-analysis with Duval and Tweedie adjustment for publication bias demonstrated that SGA resulted in significant improvements of (hypo-)manic symptoms of bipolar mixed depression as assessed by the means of the total scores of the Young Mania Rating Scale (YMRS) (SMD −0.74, 95% CI −1.20 to −0.28, n SGA = 907, control = 652). Meta-analysis demonstrated that participants in receipt of SGA (n = 979) experienced a large improvement in the Montgomery–Åsberg Depression Rating Scale (MADRS) scores (SMD −1.08, 95% CI −1.35 to −0.81, p < 0.001) vs. placebo (n = 678). Publication and measurement biases and relative paucity of studies. Overall, SGAs appear to offer favorable improvements in MADRS and YMRS scores vs. placebo. Nevertheless, given the preliminary nature of the present report, additional original studies are required to allow more reliable and clinically definitive conclusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Forest plot of the Young Mania Rating Scale (YMRS) across the included studies. CI = confidence intervals. Referenced studies: McIntyre R.S. et al., 2015 [29]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34].](https://figures.cochat.ai/paper-figures/061757f57b3b4f7bbd184144ae09b4bb/atypical-antipsychotics-in-the-treatment-of-acute-bipolar-depression-with-mixed-figure-2.jpg)
![Figure 3 Forest plot of the Montgomery–Åsberg Depression Rating Scale (MADRS) across the included studies. Referenced studies: Tohen M. et al., 2014 [14]; Patkar A. et al., 2012 [33] & Pae C.U. et al., 2012 [34]; Berk M. et al., 2015 [31]; McIntyre R.S. et al., 2015 [29].](https://figures.cochat.ai/paper-figures/bbe7fc371ecc4b39bded29f44b0f34ce/atypical-antipsychotics-in-the-treatment-of-acute-bipolar-depression-with-mixed-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pooled analysis indicates that atypical antipsychotics show a class effect in alleviating mixed features in bipolar depression, with olanzapine‐fluoxetine combination, asenapine, and lurasidone all demonstrating efficacy.319”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [319]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 8×
“Approximation of the HAM-D17 scores to the corresponding MADRS approximated values was planned when needed using conventional guidance [58].”
MethodInfluentialDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 5×
“It was possible to pool dat from three studies [14,29,33] investigating the YMRS [38] including 907 alloc ted to SGA and 652 allocated in to the control arm.”
MethodInfluentialAssessing the Quality of Randomized Trials
Clark, H. D., Wells, G. A., Huët, C., McAlister, F. A., Salmi, L. R., Fergusson, D., & Laupacis, A. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00026-4 · Cited by 648
Davey, J., Turner, R. M., Clarke, M. J., & Higgins, J. P. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-160 · Cited by 404 · cited 1×
“Indeed, as little as two studies should be acceptable for a preliminary meta-analytic report, even when accounting for heterogeneous active compounds in the same class of drugs and/or differential doses [52], whereas those meta-analysis accounting for substantially heterogeneous compounds and/or based on incomplete so…”
BackgroundSuppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060770 · Cited by 322
Goldberg, J. F., Perlis, R. H., Bowden, C. L., Thase, M. E., Miklowitz, D. J., Marangell, L. B., Calabrese, J. R., Nierenberg, A. A., & Sachs, G. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050746 · Cited by 322
The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures
Carmody, T. J., Rush, A. J., Bernstein, I., Warden, D., Brannan, S., Burnham, D., Woo, A., & Trivedi, M. H. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.04.008 · Cited by 245
Bipolar disorder—focus on bipolar II disorder and mixed depression
Benazzi, F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60453-x · Cited by 231
Publication bias in meta‐analyses from the Cochrane Database of Systematic Reviews
Kicinski, M., Springate, D. A., & Kontopantelis, E. (2015) · Statistics in Medicine · doi:10.1002/sim.6525 · Cited by 210
DSM‐5 criteria for depression with mixed features: a farewell to mixed depression
Koukopoulos, A., & Sani, G. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12140 · Cited by 181 · cited 2×
“In fact, while these latter “overlapping” trans-nosological features were excluded by the DSM-5 [15], their likely discriminant validity has nonetheless been stressed by many clinicians [25,48,50], even with regard to SGA-treatment response in acute bipolar depression [51], thus supporting the need for a broader opera…”
BackgroundMixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study
Perugi, G., Angst, J., Azorin, J.-M., Bowden, C. L., Mosolov, S., Reis, J., Vieta, E., & Young, A. H. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09092 · Cited by 175
Judd, L. L., Schettler, P. J., Akiskal, H. S., Coryell, W. H., FAWCETT, J. A., Fiedorowicz, J. G., Solomon, D. A., & Keller, M. B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.046 · Cited by 128
McIntyre, R. S., Soczynska, J. K., Cha, D. S., Woldeyohannes, H. O., Dale, R. S., Alsuwaidan, M. T., Gallaugher, L. A., Mansur, R. B., Muzina, D. J., Carvalho, A. F., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.026 · Cited by 126
Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV)
Koukopoulos, A., Sani, G., & Ghaemi, S. N. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.124404 · Cited by 123
Hayes, J., Prah, P., Nazareth, I., King, M., Walters, K., Petersen, I., & Osborn, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028725 · Cited by 121
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
Fornaro, M., De Berardis, D., Koshy, A., Perna, G., Vancampfort, D., Stubbs, B., & Valchera, A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s100846 · Cited by 115
Self-citationFind Duplicates among the PubMed, EMBASE, and Cochrane Library Databases in Systematic Review
Qi, X., Yang, M., Ren, W., Jia, J., Wang, J., Han, G., & Fan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071838 · Cited by 98
Koukopoulos׳ diagnostic criteria for mixed depression: A validation study
Sani, G., Vöhringer, P. A., Napoletano, F., Holtzman, N. S., Dalley, S., Girardi, P., Ghaemi, S. N., & Koukopoulos, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.054 · Cited by 97
McIntyre, R. S., Cucchiaro, J., Pikalov, A., Kroger, H., & Loebel, A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09410 · Cited by 78
Patkar, A., Gilmer, W., Pae, C.-U., Vöhringer, P. A., Ziffra, M., Pirok, E., Mulligan, M., Filkowski, M. M., Whitham, E. A., Holtzman, N. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034757 · Cited by 73
Carlborg, A., Ferntoft, L., Thuresson, M., & Bodegard, J. (2015) · Bipolar Disorders · doi:10.1111/bdi.12234 · Cited by 72
Benazzi, F., Berk, M., Frye, M. A., Wang, W., Barraco, A., & Tohen, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04772gre · Cited by 65
‘Bipolar Missed States’: The Diagnosis and Clinical Salience of Bipolar Mixed States
Berk, M., Dodd, S., & Malhi, G. S. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01557.x · Cited by 59
(2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019 · Cited by 55
Takeshima, M., & Oka, T. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12213 · Cited by 53
Brown, E. S., Davila, D., Nakamura, A., Carmody, T. J., Rush, A. J., Lo, A., Holmes, T., Adinoff, B., Caetano, R., Swann, A. C., et al. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12445 · Cited by 50 · cited 3×
“On the contrary, quetiapine did not reduce alcohol consumption in patients with either BD and/or depressive mixed phase and alcohol consumption when compared against placebo [30].”
MethodResultInfluentialFornaro, M., Berardis, D. D., Iasevoli, F., Pistorio, M. L., D'Angelo, E., Mungo, S., Martino, M., Ventriglio, A., Cattaneo, C. I., Favaretto, E., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.004 · Cited by 50
Self-citationEfficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features
Tohen, M. F., Kanba, S., McIntyre, R. S., Fujikoshi, S., & Katagiri, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.003 · Cited by 48
The rise and fall of the atypical antipsychotics
Kendall, T. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.083766 · Cited by 48
Mortality and secular trend in the incidence of bipolar disorder
Medici, C. R., Videbech, P., Gustafsson, L. N., & Munk‐Jørgensen, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.032 · Cited by 47
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000–2011
Hooshmand, F., Miller, S., Dore, J., Wang, P. W., Hill, S. J., Portillo, N., & Ketter, T. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.054 · Cited by 43
Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data
Bauer, M., Glenn, T., Alda, M., Sagduyu, K., Marsh, W., Grof, P., MUNOZ, R. A., Severus, E., Ritter, P. S., & Whybrow, P. C. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-5 · Cited by 43
Current Nosology of Treatment Resistant Depression: A Controversy Resistant to Revision
Fornaro, M., & Giosuè, P. (2010) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901006010020 · Cited by 42
Self-citationDunn, R. T., Stan, V. A., Chriki, L. S., Filkowski, M. M., & Ghaemi, S. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.004 · Cited by 42
Antipsychotics as antidepressants
Roberts, R. J., Lohano, K., & El‐Mallakh, R. S. (2015) · Asia-Pacific Psychiatry · doi:10.1111/appy.12186 · Cited by 41
Goldberg, J. F., Freeman, M. P., Balon, R., Citrome, L., Thase, M. E., Kane, J. M., & Fava, M. (2015) · Depression and Anxiety · doi:10.1002/da.22378 · Cited by 40
Are manic symptoms that ‘dip’ into depression the essence of mixed features?
Malhi, G. S., Fritz, K., Allwang, C., Burston, N., Cocks, C., Devlin, J., Harper, M., Hoadley, B., Kearney, B. G., Klug, P., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.009 · Cited by 38
Berk, M., Tiller, J. W. G., Zhao, J., Yatham, L. N., Malhi, G. S., & Weiller, E. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08827 · Cited by 34
Stubbs, B., Vancampfort, D., Solmi, M., Veronese, N., & Fornaro, M. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415623857 · Cited by 33
Self-citation'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states
Berk, M., Dodd, S., & Malhi, G. S. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01557.x · Cited by 31
Efficacy and Safety of Long Acting Injectable Atypical Antipsychotics: A Review
Berardis, D. D., Marini, S., Carano, A., Lang, A., Cavuto, M., Piersanti, M., Fornaro, M., Perna, G., Valchera, A., Mazza, M., et al. (2013) · Current Clinical Pharmacology · doi:10.2174/15748847113089990056 · Cited by 31
Self-citationFornaro, M., Martino, M., Pasquale, C. D., & Moussaoui, D. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.719877 · Cited by 31
Self-citationActivated Depression: Mixed Bipolar Disorder or Agitated Unipolar Depression?
Swann, A. C. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0376-1 · Cited by 29
Hu, J., Mansur, R. B., & McIntyre, R. S. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01599 · Cited by 25
A tetrachoric factor analysis validation of mixed depression
Benazzi, F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.005 · Cited by 21
Agitation for recognition by DSM-5 mixed features specifier signals fatigue?
Malhi, G. S., Fritz, K., Allwang, C., Burston, N., Cocks, C., Harper, M., Kearney, B. G., Klug, P., Meagher, L. J., Mimnagh, J., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415585858 · Cited by 18
Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?
Fornaro, M., Aguglia, E., Dell’Osso, L., & Perugi, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.632366 · Cited by 17
Self-citationGhaemi, S. N. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00557.x · Cited by 15
"Mixed" Depression: Drawbacks of DSM-5 (and Other) Polythetic Diagnostic Criteria
Maj, M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09487 · Cited by 13
Mixed Depression: A Farewell to Differential Diagnosis?
Goldberg, J. F. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09578 · Cited by 11
Fornaro, M., Berardis, D. D., Iasevoli, F., Pistorio, M. L., D׳Angelo, E., Mungo, S., Martino, M., Ventriglio, A., Cattaneo, C. I., Favaretto, E., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.014 · Cited by 10
Self-citationPae, C., Patkar, A. A., Gilmer, W. S., Holtzman, N. S., Thommi, S. B., & Ghaemi, S. N. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1297984 · Cited by 9
Bipolar disorder treatment guidelines and their limits in every day clinical practice
Perugi, G., & Fornaro, M. (2011) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 8
Self-citationRoth, L. S. (2005) · PubMed · Cited by 2
Richardson, T. H. (2012) · Bipolar Disorders · doi:10.1111/bdi.12031 · Cited by 1
Research works printed but not linked: 1
- Prieto, 2013, Exploratory factor analysis of mixed depression utilizing a modified version of Hypomania Checklist 32 (mHCL-32), Bipolar Disord., 15, 114
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Luchini, C., Stubbs, B., Solmi, M., & Veronese, N. (2017) · World Journal of Meta-Analysis · doi:10.13105/wjma.v5.i4.80 · Cited by 977
Self-citationMcIntyre, R. S., Suppes, T., Earley, W., Patel, M., & Stahl, S. M. (2020) · CNS Spectrums · doi:10.1017/s1092852919001287 · Cited by 201
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1384850 · Cited by 187
“For this reason, the task force also feels that the inclusion of this post hoc analysis in the metaanalysis by Fornaro et al. (2016) entitled ‘Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-analysis of…”
BackgroundDo Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Pompili, M., Baldessarini, R., Forte, A., Erbuto, D., Serafini, G., Fiorillo, A., Amore, M., & Girardi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101700 · Cited by 78
Metadata
- Authors
- Fornaro, M., Stubbs, B., De Berardis, D., Perna, G., Valchera, A., Veronese, N., Solmi, M., & Ganança, L.
- Affiliations
- Columbia University (US)
- King's College London (GB)
- National Health Service, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital. Mazzini, ASL 4, Teramo 64100, Italy
- Hermanas Hospitalarias del Sagrado Corazón de Jesús (IT)
- University of Padua (IT)
- University of Lisbon (PT)
- Corresponding author
- Fornaro, Michele
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-02-16
- Volume
- 17
- Issue
- 2
- Pages
- 241
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4783972
- OpenAlex
- W2284122467
- Cited by
- 53
- References
- 60
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 7 · 2017: 11 · 2016: 5
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Columbia Academic Commons (Columbia University)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- atypical antipsychotics, bipolar depression, mixed features, bipolar disorder, acute depression, manic symptoms, depressive symptoms, ziprasidone, olanzapine, lurasidone, quetiapine, asenapine, Young Mania Rating Scale, Montgomery-Asberg Depression Rating Scale
- MeSH terms
- Bipolar Disorder, Depression, Humans, Antipsychotic Agents, Treatment Outcome, Controlled Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.